RDH16 and liver cancer: In Dataset 2 (Figures 6E, F), the inverse variance weighted method again yielded a significant result (OR = 0.752, 95% CI: 0.642-0.880, P < 0.001), further supporting a protective role of RDH16 in liver cancer risk.